1. ONE HEALTH

2. The hope of
One Health

5. MEDICINE FROM ANOTHER POINT OF VIEW
ROMANIA 2016
MEDICINE FROM ANOTHER POINT OF VIEW

6. Modern medicine must be reconsidered
ACCORDING TO:
Emviroment
Genetic susceptibility
Immune status  
Relationship mucous / skin
Interrelationship nervous / immunosistem
Relationship between the cells and the body,
Relationship between energy ransfer and information

7. Medicine must be reconsidered #2
In relation with:
Society
Medical international relationship
International tourism
Regional activity
Global  interdisciplinary activities

8. IMMUNITY Immunity as a new option
Immunity as a new hope in antibiotic resistance
 The Japanese scientists say that we are in IgY ERA
Go back 5000 years ago when they mentioned the existence Psoriasis and the disease treatment and relation between the temperature as a body reaction and the disese.

9. NEW - 2016 New concept of prevention and treatment of
medicine infections and immune deficiency
New antigen structures
New immunogens: multi and poly
Standard active immunologic proteins
Personalized active immunologic proteins
Immunograma

10. ACTIVE IMMUNITY BY
PASSIVE IMMUNITY

11. A NEW CONCEPT OF PREVENTION AND TREATMENT

12. ANTIBIOTIC RESISTANCE EPIDERMOLYSIS BULLOSA
NOSOCOMIAL INFECTION
URINARY INFECTION
PSORIASIS VULGARIS
EPIDERMOLYSIS BULLOSA

13. IMMUNOLOGICALLY ACTIVE PROTEINS
THE PRODUCTS ARE:
IMMUNOLOGICALLY ACTIVE PROTEINS
UNDER PATENT PROTECTION

14. New treatment by Active Immunity Proteins
Oral treatment pass through the mucous
gargle FcRn all in all out
molecules with
V variables KDa

15. Idiotypic transfer and response
Vv molecules B lymph hyper B cell x10
T lymph mature cloned
Vv molecules info transfer

16. Vv information transfer to:
negative idiotypic cloned mature T cells transfer the information to hyperactive B cell to produce x10 more IgG –idiotypic of original antigenic information of Vv molecules This is equivalent of a good vaccine immunization or 1x 1x108 specific IgY

17. THIS GROUP OF IMMUNOLOGICALLY ACTIVE PROTEINS MEETS THE MODERN INTERNATIONAL STANDARDS REQUIRED FOR ALL NEW PRODUCTS OF THE GROUP OF BIOLOGICAL PREPARATION OR OTHER SIMILAR PRODUCTS

18. MOLECULAR WEIGHT BELOW 5 KDa ORAL ADMINISTRATION NO ADVERSE REACTIONS
THESE STANDARDS ARE
MOLECULAR WEIGHT BELOW 5 KDa
ORAL ADMINISTRATION
NO ADVERSE REACTIONS
NO IDIOTYPIC REACTIONS
EFFICACY

19. IMMUNOLOGICALLY ACTIVE PROTEINS
Molecular weight: KDa
Oral administration: all mucosa and skin
Adverse reactions: NO
Idiotypic reactions: NO
Efficacy: specific and nonspecific

20. Anticorpi anti-biologice ( ADAS )
o potențială limitare în utilizarea medicamentelor biologice folosite in tratarea psoriazisului, reumatismului si al altor afectiuni

21. Raspunsul idiotype al organismului uman la anticorpii monoclonali de mamfier

22. McaB versus Pa PC2

23. PC2 generatia II-a de produse biologice
Specificatia Medicamente Produse
biologice biologice PC2
Origine soarice si om gaina
Reactii adverse
Reactii imune
Administrare PARENTERALA ORALA
Antimicrobiana NU DA
Eficienta terapeutica limitata complexa

24. Produse biologice PC2
Ovomucina β kda
Ovomucina α 254 kda
IgY kDa
Ovotransferina 85.0kDA
Ovalbumin kDa
LYSOZYME 13,4kDa
Peptide ovoalb aminoacizi
2 aminoacizi

27. MEDICAL INFECTIONS Antibiotic-resistant infections 12/16
Nosocomial infections /11
Urinary infections /120

28. PSORIASIS
healed

29. New psoriasis treatement
1. Oraly treatment by IAP
2. Oraly local treatment by IAP
3. Skin treatment with IAP

30. 1. healed clinical simptoms
2. Prevention of new simptoms by treatment
3. Psohological treatment of the patient
4. Recuperatory treatment of the patient

31. The first child to be cured of psoriasis
A 6 years old girl with generalized
psoriasis vulgaris was cured after
oral and cutaneous treatment with
biologically active products

32. Treatment of children psoriasis
healed / total
______________
/ 23

33. Psoriatic wounds

34. Psoriatic wounds

35. Psoriasis Vulgaris in adults
healed /212
recovered over 60% /212

36. 76 years old patient General psoriasis for 55 years MRSA-infected Oral and topical treatment Healed Normal skin!!! Immunological support by oral treatment

37. Generalized psoriasis with MRSA

38. EPIDERMOLYSIS BULLOSA

39. The first child to be clinically cured of Epidermolisys bullosa

46. EB-3

48. Wounds healed /total Digestive tube 4/4 Respiratory tract 3/3 Skin Staphylococcus aureus 4/4 Healing scars 3/4

49. New concept for psoriasis treatment

50. PROPOSALS/SUGGESTIONS
1. To have an international scientific activity
2. To treat a group of children in Romania under international control
3. To extend studies on immunological IAP treatment as such or with alternatives
4. To change topical treatment or bandages using standard or personalized IAP

51. To take as example these girls from Romania and extend microbiological, immunological and genetic studies
To step in by psychiatric methods, recovery therapies etc
Preventive medicine of new blisters
A state of wellbeing